Business: a leading global manufacturer of hard empty capsules. HQ: Basel, Switzerland
Joint Global Coordinators and Physical Bookrunners: GS (B&D), Jefferies, BNP, and UBS
Joint Bookrunners: BBVA, ING, IMI - Intesa Sanpaolo, RBI, SocGen, UniCredit, and Standard Chartered
Size: expected Min €500m
Format: 144A/Reg S
Instrument: Senior Secured Notes
Ratings: B1/B+ (stable/stable)
Use of Proceeds: along with proceeds from equity contribution, and a USD/EUR term loan B 2-part (USD$500m minimum and EUR500m minimum) (total loan and bond deal size CHF1.38bn equivalent). to fund the CHF2bn purchase price for the acquisition of a 60% interest in Capsugel by Lone Star from Lonza Group AG (which will retain a 40% minority interest) and provide for cash overfunding to the balance sheet.
Tenor: 7 year
Call Schedule: NC3 (MWC B+50bp) (50%,25%,par). Equity claw: 3y 40%. Special call: 10% per year the first 2 years at 103
List: ISE
Law: NY
Denoms: 100kx1k
Equity sponsor: Lone Star
Equity contribution: CHF823m, including Lonza's rollover equity.
Roadshow (virtual meetings): start 27-Apr-26
Global Investor Call: 15:00 UKT / 10:00 ET 27-Apr-26
Netroadshow direct link: https://urldefense.com/v3/__https:/www.netroadshow.com/nrs/home/*!/?show=bf5c1c4a__;Iw!!O2kDR7mm-zSJ!qLX_5QW9_uiWcE1TqrJb7_o9abmY_G1Q4QE5RlkdmcUCeJrQVHEt6nuDc7Uf9_cQ-R_CV7_u0AZ94gc$
Commitments due: USD TLB 30-Apr-26 17:00 NYT / 22:00 UKT; EUR TLB 01-May-26 11:00 UKT / 06:00 NYT
Timing: possible pricing 01-May
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.